Cervical cancer: Part I human papilloma virus vaccination in Taiwan

Yang, Szu-Ting; Wang, Peng-Hui; Liu, Hung-Hsien; Chang, Wen-Hsun; Chou, Fang-Wei; Lee, Wen-Ling

doi:10.1016/j.tjog.2024.04.005

Taiwanese Journal of Obstetrics and Gynecology

2024

DOI: 10.1016/j.tjog.2024.04.005

|View full text |Cite

Cervical cancer: Part I human papilloma virus vaccination in Taiwan

Szu-Ting Yang,

Peng-Hui Wang,

Hung-Hsien Liu

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 8 publications

References 74 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

The selection of immune checkpoint inhibitors of programmed cell death (anti-PD-1) and its ligand (anti-PD-L1) makes matters more challenges for clinical practice

Wang,

Yang,

Liu

2024

Taiwanese Journal of Obstetrics and Gynecology

View full text Add to dashboard Cite

The selection of immune checkpoint inhibitors of programmed cell death (anti-PD-1) and its ligand (anti-PD-L1) makes matters more challenges for clinical practice

Wang,

Yang,

Liu

2024

Taiwanese Journal of Obstetrics and Gynecology

View full text Add to dashboard Cite

Surgery-based radiation-free multimodality treatment for locally advanced cervical cancer

Chang,

Yang,

Liu

et al. 2024

Taiwanese Journal of Obstetrics and Gynecology

View full text Add to dashboard Cite

Cervical cancer: Part II the landscape of treatment for persistent, recurrent and metastatic diseases (I)

Yang,

Wang,

Liu

et al. 2024

Taiwanese Journal of Obstetrics and Gynecology

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Cervical cancer: Part I human papilloma virus vaccination in Taiwan

Cited by 8 publications

References 74 publications

The selection of immune checkpoint inhibitors of programmed cell death (anti-PD-1) and its ligand (anti-PD-L1) makes matters more challenges for clinical practice

The selection of immune checkpoint inhibitors of programmed cell death (anti-PD-1) and its ligand (anti-PD-L1) makes matters more challenges for clinical practice

Surgery-based radiation-free multimodality treatment for locally advanced cervical cancer

Cervical cancer: Part II the landscape of treatment for persistent, recurrent and metastatic diseases (I)

Contact Info

Product

Resources

About